Borosil Scientific Limited Releases Q3FY26 Investor Presentation on Unaudited Financial Results

2 min read Updated on 13 Feb 2026, 03:34 PM

Reviewed by

Shriram SScanX News Team

Overview

Borosil Scientific Limited released its Q3FY26 investor presentation on February 13, 2026, covering unaudited financial results for the quarter and nine months ended December 31, 2025. The company, with a market cap of ₹938 crores, operates as a market leader in laboratory glassware with 4,000+ SKUs across four verticals and four manufacturing locations in India, serving over 90 countries globally.

*this image is generated using AI for illustrative purposes only.

Borosil Scientific Limited has released its comprehensive investor presentation covering the unaudited financial results for the quarter and nine months ended December 31, 2025. The presentation was formally submitted to stock exchanges on February 13, 2026, by Company Secretary Sanjay Gupta in compliance with Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements.

Company Overview and Market Position

Borosil Scientific Limited operates as one of the market leaders in laboratory glassware and scientific instruments, holding a market capitalization of ₹938 crores as of February 10, 2026. The company is part of the larger Borosil Group, which includes Borosil Renewables Ltd (₹6989 crores market cap) and Borosil Ltd (₹2966 crores market cap).

Parameter	Details
Market Cap	₹938 crores
BSE Scrip Code	544184
NSE Trading Symbol	BOROSCI
Product Range	4,000+ SKUs
Manufacturing Locations	4 facilities in India

Legacy and Market Leadership

The presentation emphasized Borosil Scientific's six-decade journey since 1962, when it pioneered borosilicate glassware introduction in India. The company has established itself as the gold standard in laboratory glassware, with three out of four lab glassware products in India bearing the Borosil name. The company serves diverse sectors including pharmaceuticals, research, academia, and various industries across India.

Operational Infrastructure

Borosil Scientific's operational network demonstrates significant scale and reach across India. The company operates through four manufacturing locations in Bharuch, Nashik, Pune, and Vadodara, supported by four warehouses providing pan-India coverage. The distribution network includes over 150 channel partners across India, enabling 24-hour delivery capability.

Infrastructure Component	Count/Details
Manufacturing Facilities	4 locations
Warehouses	4 pan-India
Channel Partners	150+
Export Countries	90+ globally
Business Verticals	4 segments

Product Portfolio and Innovation

The company's product portfolio spans four main verticals: laboratory glassware and consumables, laboratory equipment, process equipment, and pharmaceutical primary packaging. Recent product developments include fiber analysis equipment, micro vials, moisture analyzers, handheld photometers, and UV visible spectrophotometers. The company holds patents for products like the LabQuest dispenser and features QR-coded volumetric glassware.

Strategic Initiatives and Certifications

Borosil Scientific maintains multiple certifications including ISO 9001:2015, 14001, 45001, and 15378, along with NABL accredited calibration laboratory status. The company received recognition through the India Manufacturing Excellence Award (Silver) in December 2025 and the TPM Significant Achievement Award from CII in December 2025. The presentation highlighted the company's commitment to environmental, social, and governance (ESG) practices integrated into core operations.

Historical Stock Returns for BOROSCI

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.09%	-3.73%	+0.47%	-20.77%	-18.64%	-28.40%

BOROSCI

View Company Insights

View All News

Borosil Scientific Q3FY26 Results: Net Profit Surges 52.8%, Revenue Grows 14.4%

1 min read Updated on 05 Feb 2026, 02:37 PM

Reviewed by

Jubin VScanX News Team

Add as a preferred
source on Google

Overview

Borosil Scientific delivered impressive Q3FY26 financial performance with net profit increasing 52.8% year-on-year to 1,021.07 lakhs and revenue from operations growing 14.4% to 10,712.04 lakhs. The Scientific segment led growth with 16.1% revenue increase, while the company reported exceptional items of 191.51 lakhs related to new Labour Code implementation.

*this image is generated using AI for illustrative purposes only.

Borosil Scientific has announced its unaudited financial results for the quarter ended December 31, 2025, demonstrating robust performance across key financial metrics. The company's Board of Directors approved these results at their meeting held on February 11, 2026, marking a significant turnaround from previous quarters.

Strong Financial Performance

The company delivered impressive financial results for Q3FY26, showing substantial improvement across all major performance indicators compared to the corresponding quarter in the previous year.

Financial Metric:	Q3FY26	Q3FY25	Change (%)
Revenue from Operations:	10,712.04 lakhs	9,364.84 lakhs	+14.4%
Net Profit:	1,021.07 lakhs	668.42 lakhs	+52.8%
Total Income:	10,975.55 lakhs	9,541.58 lakhs	+15.0%
Earnings Per Share:	1.15	0.75	+53.3%

Segment-wise Performance Analysis

Borosil Scientific operates across three key business segments, with the Scientific segment leading the growth momentum during the quarter.

Segment:	Q3FY26 Revenue	Q3FY25 Revenue	Growth (%)
Scientific - Laboratory Glass & Equipment:	7,316.63 lakhs	6,303.68 lakhs	+16.1%
Glassware:	3,281.05 lakhs	2,943.23 lakhs	+11.5%
Others:	114.36 lakhs	117.93 lakhs	-3.0%

Exceptional Items Impact

The company reported exceptional items totaling 191.51 lakhs during the quarter, primarily related to the implementation of new Labour Codes. The Government of India consolidated 29 existing labour legislations into four Labour Codes effective November 21, 2025, resulting in a one-time incremental impact for the company.

Nine-Month Performance Overview

For the nine months ended December 31, 2025, the company maintained strong performance momentum with revenue from operations reaching 29,561.13 lakhs compared to 27,478.88 lakhs in the corresponding period last year. Net profit for the nine-month period stood at 1,818.89 lakhs, though this was lower than 2,084.25 lakhs in the previous year, primarily due to exceptional items totaling 852.82 lakhs related to the Voluntary Retirement Scheme settlement.

Corporate Actions and Governance

The company allotted 13,747 equity shares during the nine-month period under the "Borosil Scientific Limited - Special Purpose Employee Stock Option Plan 2023", resulting in an increase in paid-up equity share capital by 0.14 lakhs and securities premium by 15.14 lakhs. The paid-up equity share capital stands at 889.47 lakhs as of December 31, 2025.

Historical Stock Returns for BOROSCI